Escitalopram in major depressive disorder: clinical benefits and cost effectiveness versus citalopram

By Lançon Christophe   Verpillat Patrice   Annemans Lieven   Despiegel Nicolas   François Clément  

International Journal of Psychiatry in Clinical Practice, Vol. 11, Iss. 1, 2007-01 ,pp. : 44-52

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Cost effectiveness analysis of escitalopram compared to venlafaxine and fluvoxamine in treatment of major depressive disorder

By Xie Feng   Despiegel Nicolas   Danchenko Natalya   Hansen Karina  

International Journal of Psychiatry in Clinical Practice, Vol. 13, Iss. 1, 2009-03 ,pp. : 59-69

Ashgate Publishing Ltd

Access to resources Recommend Favorite

A cost-effectiveness analysis of escitalopram as first line treatment of depression in Sweden

By Löthgren Mickael   Hemels Michiel   François Clément   Jönsson Bengt  

Primary Care Psychiatry, Vol. 9, Iss. 4, 2004-12 ,pp. : 153-162

Informa Healthcare

Access to resources Recommend Favorite

Escitalopram in the Long-term Treatment of Major Depressive Disorder

By Wade Alan   Despiegel Nicolas   Heldbo Reines Elin  

Annals of Clinical Psychiatry (after Jan 1, 2004), Vol. 18, Iss. 2, 2006-05 ,pp. : 83-89

Informa Healthcare

Access to resources Recommend Favorite

Major depressive disorder and response to citalopram treatment in women attending menopause clinic

By Belső Nóra   Kiss Kitty   Rihmer Zoltán   Tüzkő Nándor   Tóth Sándor János   Paulin Ferenc  

International Journal of Psychiatry in Clinical Practice, Vol. 7, Iss. 4, 2003-12 ,pp. : 269-272

Ashgate Publishing Ltd

Access to resources Recommend Favorite